XML 20 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Operating Activities      
Net income $ 42,572 $ 54,498 $ 53,376
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 17,655 15,007 13,035
Amortization of bond premiums 13 47 249
Allowance for Doubtful Accounts Receivable, Period Increase (Decrease) 174 179 (25)
Provision for excess and obsolete inventories 152 264 625
Share-based compensation 7,374 6,458 4,357
(Gain) loss on disposition of assets (12) 45 (20)
Foreign currency transaction loss (gain) 55 (59) (22)
Interest income on note receivable (27) (25) (28)
Deferred income taxes 2,849 (1,554) 825
Changes in assets and liabilities:      
Accounts receivable (2,832) (7,516) 7,048
Income tax receivable (4,461) 4,596 (1,537)
Inventories (5,598) (23,698) (9,478)
Prepaid expenses and other (528) 98 (83)
Accounts payable (1,176) 3,043 654
Deferred revenue 412 258 417
Accrued liabilities and donations (1,766) 6,353 (5,470)
Net cash provided by operating activities 54,856 57,994 63,923
Investing Activities      
Capital expenditures (37,268) (41,713) (26,604)
Cash paid in business combination (6,377) 0 0
Proceeds from sale of property, plant and equipment 13 10 28
Investment in certificates of deposits (7,200) (5,280) (4,112)
Maturities of certificates of deposits 10,080 7,912 10,560
Purchase of investments held to maturity (9,001) (13,241) (10,384)
Maturities of investments 14,570 19,700 10,021
Proceeds from called investments 495 1,500 3,514
Principal payments from note receivable 53 60 52
Net cash used in investing activities (34,635) (31,052) (16,925)
Financing Activities      
Borrowings under revolving credit facility 0 0 761
Payments under revolving credit facility 0 0 (761)
Stock options exercised 4,987 2,259 2,063
Repurchase of stock (26,846) (16,620) (19,317)
Employee taxes paid by withholding shares (1,097) (1,614) (823)
Cash dividends paid to stockholders (16,728) (13,663) (12,676)
Net cash used in financing activities (39,684) (29,638) (30,753)
Net (decrease) increase in cash and cash equivalents (19,463) (2,696) 16,245
Cash and cash equivalents, beginning of year 21,457 24,153 7,908
Cash and cash equivalents, end of year $ 1,994 $ 21,457 $ 24,153